A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers

Immune checkpoint inhibitor (ICI) have demonstrated efficacy in treating various cancers by modulating the immune system, but this can lead to immune-related adverse events (irAEs), including myocarditis. ICI-associated myocarditis is a rare but highly lethal irAE with a short mean time to onset, an...

詳細記述

書誌詳細

出版年:	Human Vaccines & Immunotherapeutics
主要な著者:	Le Xu, Yukai Chen, Lin Xiong, Yang Shen, Zhuolin Zhou, Siyu Wang, Ximing Xu
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2025-12-01
主題:	Biomarkers irAEs immune checkpoint inhibitors myocarditis pharmacology
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/21645515.2025.2512645